Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.7B | 11.3B | 11.2B | 10.9B |
Cost of revenue | 9.9B | 8.0B | 8.2B | 7.8B |
Gross profit | 2.8B | 3.4B | 3.1B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.8B | 1.8B | 1.7B | 1.8B |
Operating income | 304.7M | 910.9M | 787.5M | 748.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 62.1M | 28.8M | 42.6M | 33.9M |
Other income expense | — | — | — | — |
Pretax income | 491.8M | 972M | 942.3M | 1.0B |
Tax provision | 173.1M | 258.4M | 249.2M | 236.2M |
Net income | 318.7M | 713.6M | 693.1M | 767.1M |
Basic EPS | — | 1.6 | 1.5 | 1.7 |
Diluted EPS | — | 1.6 | 1.5 | 1.7 |
Basic average shares | — | 457.6M | 459.1M | 459.3M |
Diluted average shares | — | 457.6M | 459.1M | 459.3M |
EBITDA | 872M | 1.3B | 1.3B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 300K | 300K | -100K | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |